Plotkin SR et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24(9):1967–1977. https://doi.org/10.1016/j.gim.2022.05.007

Article  CAS  PubMed  Google Scholar 

Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80(4):805–810. https://doi.org/10.1086/513207

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piotrowski A et al (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46(2):182–187. https://doi.org/10.1038/ng.2855

Article  CAS  PubMed  Google Scholar 

Evans DG et al (2022) ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis. Eur J Hum Genet 30(7):812–817. https://doi.org/10.1038/s41431-022-01086-x

Article  PubMed  PubMed Central  Google Scholar 

Forde C et al (2024) Related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study. J Med Genet 61(9):856–860. https://doi.org/10.1136/jmg-2024-110065

Article  CAS  PubMed  Google Scholar 

Agnihotri S et al (2016) The genomic landscape of schwannoma. Nat Genet 48(11):1339–1348. https://doi.org/10.1038/ng.3688

Article  CAS  PubMed  Google Scholar 

Mansouri S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141(1):101–116. https://doi.org/10.1007/s00401-020-02230-x

Article  CAS  PubMed  Google Scholar 

Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18(24):3016–3027. https://doi.org/10.1101/gad.1262504

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rivera B et al (2020) DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis. J Clin Invest 130(3):1479–1490. https://doi.org/10.1172/JCI130206

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. International Agency for Research on and O. World Health, B. Who Classification of Tumours Editorial, Ed. WHO Classification of Endocrine and Neuroendocrine Tumors, 5 ed. IARC, 2022

Chan-Pak-Choon F et al (2023) SMARCA4-associated schwannomatosis. Acta Neuropathol 145(4):505–507. https://doi.org/10.1007/s00401-023-02546-4

Article  PubMed  Google Scholar 

Nogué C et al (2022) DGCR8 and the six hit, three-step model of schwannomatosis. Acta Neuropathol 143(1):115–117. https://doi.org/10.1007/s00401-021-02387-z

Article  CAS  PubMed  Google Scholar 

Condello V et al (2024) Prevalence, molecular landscape, and clinical impact of DICER1 and DGCR8 mutated follicular-patterned thyroid nodules. J Clin Endocrinol Metab 109(7):1733–1744. https://doi.org/10.1210/clinem/dgae034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kehrer-Sawatzki H, Mautner VF, Cooper DN (2017) Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet 136(4):349–376. https://doi.org/10.1007/s00439-017-1766-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Kock L, Rivera B, Foulkes WD (2020) Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8. Acta Neuropathol 139(6):1115–1118. https://doi.org/10.1007/s00401-020-02139-5

Article  PubMed  Google Scholar 

Liu APY et al (2020) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol 139(2):259–271. https://doi.org/10.1007/s00401-019-02106-9

Article  CAS  PubMed  Google Scholar 

Nguyen L, Crawford JR (2018) Pineoblastoma in a child with 22q11.2 deletion syndrome. BMJ Case Rep. https://doi.org/10.1136/bcr-2018-226434

Article  PubMed  PubMed Central  Google Scholar 

Li BK et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a rare brain tumor consortium registry study. Acta Neuropathol 139(2):223–241. https://doi.org/10.1007/s00401-019-02111-y

Article  CAS  PubMed  Google Scholar 

Liu APY et al (2021) Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol 141(5):771–785. https://doi.org/10.1007/s00401-021-02284-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans DG et al (2021) Typical 22q11.2 deletion syndrome appears to confer a reduced risk of schwannoma. Genet Med 23(9):1779–1782. https://doi.org/10.1038/s41436-021-01175-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahmad HF et al (2023) Clinical significance of SOX10 expression in human pathology. Curr Issues Mol Biol 45(12):10131–10158. https://doi.org/10.3390/cimb45120633

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morshed RA, Lee AT, Lee YM, Chin CT, Jacques L (2019) Schwannomatosis of the spinal accessory nerve: a case report. J Brachial Plex Peripher Nerve Inj 14(1):e9–e13. https://doi.org/10.1055/s-0039-1685457

Article  PubMed  PubMed Central  Google Scholar 

Wali AA, Yang R, Merbs SL, Rodriguez FJ, Eberhart CG, Lucas CG (2023) Orbital SOX10-mutant schwannoma with plexiform growth: Expanding the histopathological spectrum of a new molecular group. J Neuropathol Exp Neurol 82(11):963–965. https://doi.org/10.1093/jnen/nlad080

Article  PubMed  PubMed Central  Google Scholar 

Williams EA et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol 25(12):2221–2236. https://doi.org/10.1093/neuonc/noad121

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terry M et al (2023) Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. Acta Neuropathol 146(6):857–860. https://doi.org/10.1007/s00401-023-02641-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee PH et al (2025) In-frame insertions of SOX10 are highly enriched and characterize a distinct transcriptomic profile in gastrointestinal schwannomas. J Pathol 266(3):268–279. https://doi.org/10.1002/path.6426

Article  CAS  PubMed  Google Scholar 

Robertson KD, Jones PA (1999) Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene 18(26):3810–3820. https://doi.org/10.1038/sj.onc.1202737

Article  CAS  PubMed  Google Scholar 

Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83(6):993–1000. https://doi.org/10.1016/0092-8674(95)90214-7

Article  CAS  PubMed  Google Scholar 

Goldstein AM et al (2006) High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 66(20):9818–9828.